← Back to Analyst Consensus 
AAPG Buy
ASCENTAGE PHARMA GROUP INTERNATIONAL
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 3 upgrades / ▼ 0 downgrades / 1 reiterations from 4 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Oct 14, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Oct 13, 2026 | Citizens | initiate | — → Market Outperform | — | 46% |
| Oct 8, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 21, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 15, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 10, 2026 | B. Riley Securities | initiate | — → Buy | — | 55% |
| Apr 13, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 26, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Dec 4, 2025 | Oppenheimer | initiate | — → Outperform | $45 | 52% |
| Nov 24, 2025 | Truist Securities | initiate | — → Buy | $51 | 55% |
| Nov 10, 2025 | BTIG | initiate | — → Buy | $50 | 52% |
| Nov 5, 2025 | Piper Sandler | initiate | — → Overweight | $48 | 54% |
| Mar 27, 2025 | JP Morgan | initiate | — → Overweight | $0 | 54% |
Price Target Trend
Apr 25, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days